AndroGel, manufactured by Abbott Laboratories, is the most common of the many prescription products developed for use as daily testosterone replacement therapy. It is also involved in one of a number of testosterone therapy lawsuits, claiming that the drug increases a man’s risk of stroke, heart attack, and possible death. In addition, the drug may have these side effects for men: low sperm count, enlarged breasts, blood clots in the legs, hypertension, and sleep apnea, among other problems. The development of such complications has thousands of users filing AndroGel lawsuits.
AndroGel 1% (FDA approved in 2000) and AndroGel 1.62% (FDA approved in 2011) are to be used daily applied to shoulders and upper arms. AndroGel 1% may also be used on the stomach. All areas should be covered after the gel is applied, and non-users should not be allowed to come in contact with the covered areas.
In January 2014, the U.S. Food and Drug Administration announced its investigation of AndroGel and other such treatment for men both under and over the age of 65. The investigation was prompted by the results of two studies. In one, the records of 55,593 men, most under 65, on testosterone therapy were examined. Results showed a twofold increase in heart attack risk shortly after therapy began for those under 65, and it confirmed a twofold increase for those over 65. In the other study, published in JAMA in 2013, a possible connection between testosterone therapy and stroke and heart attacks was examined. The results showed that men without testosterone therapy had a 19.9% chance of a stroke or heart attack, whereas the figure was 25.76% for men on testosterone therapy.
In addition to prompting an investigation, such studies have caused the FDA to caution health care professionals about the potential risks with ordering this kind of treatment. Health care professionals elsewhere are also conducting clinical trials, such as a study of low-dose testosterone to treat depression in women at Massachusetts General Hospital in Boston, or the role of testosterone in the progression of Alzheimer’s disease in Perth, Australia.
On February 4th, 2014, five men filed AndroGel lawsuits against Abbott Laboratories just four days after the FDA safety announcement was released. These men claimed that they they suffered heart attacks, strokes, and one had a mini-stroke. Life threatening complications such as these can cause permanent injuries and leave victims with medical expenses and hospital bills to pay
As increases in incidences begin to emerge, attorneys predict a rise in the number of AndroGel lawsuits as well considering this product is the number one treatment of low testosterone in America. It is alleged by many AndroGel users that the manufacturing company did not adequately warn of the possible side effects of its use. This product has been marketed with such great focus on benefits that only two percent of men undergoing testosterone therapy suffer from insufficient levels of this hormone. The consequences of choosing this method of low testosterone treatment may be serious.
If you are taking AndroGel or any other low testosterone therapy treatment and you are experiencing any side effect, no matter how slight at present, or if you have suffered a stroke or heart attack, contact an AndroGel lawyer immediately. An experienced attorney can discuss your options and help you receive the compensation and justice you deserve.